Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1h-indol-3-yl)butyl)-1-piperazinyl)-, Hydrochloride (1:1)
2. 5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperazinyl)benzofuran-2-carboxamide
3. 68843, Emd
4. Emb 68843
5. Emb-68843
6. Emb68843
7. Emd 68843
8. Hcl, Vilazodone
9. Hydrochloride, Vilazodone
10. Viibryd
11. Vilazodone
12. Vilazodone Hcl
1. 163521-08-2
2. Vilazodone Hcl
3. Viibryd
4. Vilazodone (hydrochloride)
5. Emd-68843
6. Emd 68 843
7. Vilazodone Hydrochloride [usan]
8. 5-(4-(4-(5-cyano-1h-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide Hydrochloride
9. Emd 68843
10. U8htx2gk8j
11. Sb659746-a
12. 163521-08-2 (hcl)
13. Chebi:70705
14. Sb659746a
15. 5-[4-[4-(5-cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide Hydrochloride
16. Sb 659746a
17. Sb-659746a
18. Sb-659746-a
19. Vilazodone Hydrochloride (usan)
20. 5-(4-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-yl)benzofuran-2-carboxamide, Hydrochloride
21. 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide Hydrochloride
22. 2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1h-indol-3-yl)butyl)-1-piperazinyl)-, Hydrochloride (1:1)
23. 5-(4-(4-(5-cyano-1h-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide Monohydrochloride
24. 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide;hydrochloride
25. 5-{4-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide Hydrochloride
26. Unii-u8htx2gk8j
27. Vilazodonei
28. 2-benzofurancarboxamide, 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]-1-piperazinyl]-, Hydrochloride (1:1)
29. Viibryd (tn)
30. Vilazodonehydrochloride
31. Vilazodone Monohydrochloride
32. Schembl867358
33. Chembl1615374
34. Dtxsid80936833
35. Bcp11496
36. Emd68843
37. Mfcd00940014
38. S4259
39. Vilazodone Hydrochloride [mi]
40. Akos024464039
41. Ccg-213313
42. Cs-0549
43. Vilazodone Hydrochloride [mart.]
44. Vilazodone Hydrochloride [vandf]
45. Vilazodone Hydrochloride [who-dd]
46. 5-{4-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboximidic Acid--hydrogen Chloride (1/1)
47. Ac-25885
48. As-74699
49. Emd 68843;sb659746a
50. Hy-14261
51. Vilazodone Hydrochloride, >=98% (hplc)
52. A3919
53. Sw219887-1
54. V0149
55. Vilazodone Hydrochloride [orange Book]
56. D09699
57. 521v128
58. J-525160
59. Q27139037
60. 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine Hydrochloride
61. 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)piperazine Hydrochloride
62. 1-[4-(5-cyanoindol-3-yl)butyl]4-(2-carbamoyl-benzofuran-5-yl)-piperazine Hydrochloride
63. 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2carboxamide Hydrochloride
64. 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxamide Hydrochloride
65. 4-(2-carbamoyl-1-benzofuran-5-yl)-1-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-ium Chloride
66. Vilazodone Hydrochloride Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material
| Molecular Weight | 478.0 g/mol |
|---|---|
| Molecular Formula | C26H28ClN5O2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | 477.1931528 g/mol |
| Monoisotopic Mass | 477.1931528 g/mol |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 729 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Viibryd |
| PubMed Health | Vilazodone (By mouth) |
| Drug Classes | Antidepressant |
| Drug Label | VIIBRYD Tablets for oral administration contain polymorph Form IV vilazodone hydrochloride (HCl), a selective serotonin reuptake inhibitor and a 5HT1A receptor partial agonist.Vilazodone HCl is 2-benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)... |
| Active Ingredient | Vilazodone hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 10mg; 40mg; 20mg |
| Market Status | Prescription |
| Company | Forest Labs |
| 2 of 2 | |
|---|---|
| Drug Name | Viibryd |
| PubMed Health | Vilazodone (By mouth) |
| Drug Classes | Antidepressant |
| Drug Label | VIIBRYD Tablets for oral administration contain polymorph Form IV vilazodone hydrochloride (HCl), a selective serotonin reuptake inhibitor and a 5HT1A receptor partial agonist.Vilazodone HCl is 2-benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)... |
| Active Ingredient | Vilazodone hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 10mg; 40mg; 20mg |
| Market Status | Prescription |
| Company | Forest Labs |
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
Selective Serotonin Reuptake Inhibitors
Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)
Serotonin 5-HT1 Receptor Agonists
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
About the Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios ...
About the Company : Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutica...

About the Company : Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in mark...

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

About the Company : Nosch Labs Pvt. Ltd. is a leading pharmaceutical company specializing in the development, manufacturing, and commercialization of high-quality Active Pharmaceutical Ingredients (AP...

About the Company : Raghava Life Sciences Pvt. Ltd. (RLS), established in the year 2018, is an integrated small molecules chemistry Contract research, Development and Manufacturing Organization (CDMO)...

About the Company : Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals...

About the Company : In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (N...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
99
PharmaCompass offers a list of Vilazodone Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vilazodone Hydrochloride manufacturer or Vilazodone Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vilazodone Hydrochloride manufacturer or Vilazodone Hydrochloride supplier.
A Vilazodone HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vilazodone HCl, including repackagers and relabelers. The FDA regulates Vilazodone HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vilazodone HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vilazodone HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Vilazodone HCl supplier is an individual or a company that provides Vilazodone HCl active pharmaceutical ingredient (API) or Vilazodone HCl finished formulations upon request. The Vilazodone HCl suppliers may include Vilazodone HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Vilazodone HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Vilazodone HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Vilazodone HCl active pharmaceutical ingredient (API) in detail. Different forms of Vilazodone HCl DMFs exist exist since differing nations have different regulations, such as Vilazodone HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vilazodone HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Vilazodone HCl USDMF includes data on Vilazodone HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vilazodone HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vilazodone HCl suppliers with USDMF on PharmaCompass.
A Vilazodone HCl written confirmation (Vilazodone HCl WC) is an official document issued by a regulatory agency to a Vilazodone HCl manufacturer, verifying that the manufacturing facility of a Vilazodone HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vilazodone HCl APIs or Vilazodone HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Vilazodone HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Vilazodone HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vilazodone HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vilazodone HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vilazodone HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vilazodone HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vilazodone HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vilazodone HCl suppliers with NDC on PharmaCompass.
Vilazodone HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vilazodone HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vilazodone HCl GMP manufacturer or Vilazodone HCl GMP API supplier for your needs.
A Vilazodone HCl CoA (Certificate of Analysis) is a formal document that attests to Vilazodone HCl's compliance with Vilazodone HCl specifications and serves as a tool for batch-level quality control.
Vilazodone HCl CoA mostly includes findings from lab analyses of a specific batch. For each Vilazodone HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vilazodone HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Vilazodone HCl EP), Vilazodone HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vilazodone HCl USP).